Skip to content

Clinical trials

Phase 1 Obesity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 1 Country / region: Germany Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20091
20101
20131
20141
20161
20181
20193
20203
20223
20233
20247
20254
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting9
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S18
Boehringer Ingelheim9
Zealand Pharma5
AstraZeneca3
Beta-Stim Ltd.1
Eli Lilly and Company1
Hoffmann-La Roche1
MEDIGREIF Inselklinik Heringsdorf1
Rhine-Westphalia Institute for Economic Research1
Sensate LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity42
Overweight22
Diabetes Mellitus, Type 27
Nutrition Disorders3
Arthritis, Rheumatoid1
Atherosclerosis1
Body Weight1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Endocrine System Diseases1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.